Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1971 2
1973 1
1975 3
1976 4
1977 6
1978 5
1979 4
1980 11
1981 14
1982 14
1983 16
1984 25
1985 14
1986 17
1987 26
1988 36
1989 31
1990 35
1991 37
1992 42
1993 35
1994 38
1995 43
1996 40
1997 38
1998 36
1999 43
2000 47
2001 62
2002 69
2003 71
2004 73
2005 74
2006 73
2007 94
2008 125
2009 122
2010 146
2011 168
2012 185
2013 185
2014 271
2015 309
2016 288
2017 286
2018 400
2019 355
2020 482
2021 542
2022 520
2023 583
2024 175

Text availability

Article attribute

Article type

Publication date

Search Results

5,622 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.
Glenner GG, Wong CW. Glenner GG, et al. Biochem Biophys Res Commun. 1984 May 16;120(3):885-90. doi: 10.1016/s0006-291x(84)80190-4. Biochem Biophys Res Commun. 1984. PMID: 6375662
A purified protein derived from the twisted beta-pleated sheet fibrils in cerebrovascular amyloidosis associated with Alzheimer's disease has been isolated by Sephadex G-100 column chromatography with 5 M guanidine-HC1 in 1 N acetic acid and by high performance liqu …
A purified protein derived from the twisted beta-pleated sheet fibrils in cerebrovascular amyloidosis associated with Alzheimer's dis …
The multifaceted effects of YTHDC1-mediated nuclear m(6)A recognition.
Widagdo J, Anggono V, Wong JJ. Widagdo J, et al. Trends Genet. 2022 Apr;38(4):325-332. doi: 10.1016/j.tig.2021.11.005. Epub 2021 Dec 14. Trends Genet. 2022. PMID: 34920906 Review.
N6-methyladenosine or m(6)A modification to mRNAs is now recognised as a key regulator of gene expression and protein translation. The fate of m(6)A-modified mRNAs is decoded by m(6)A readers, mostly found in the cytoplasm, except for the nuclear-localised YT …
N6-methyladenosine or m(6)A modification to mRNAs is now recognised as a key regulator of gene expression and protein translation. Th …
Many Facets of Left Ventricular Dyssynchrony.
Soman P, Malhotra S, Wong T, Jain S. Soman P, et al. Circ Cardiovasc Imaging. 2021 Jul;14(7):e013060. doi: 10.1161/CIRCIMAGING.121.013060. Epub 2021 Jul 20. Circ Cardiovasc Imaging. 2021. PMID: 34281364 No abstract available.
Mass Analyzers and Mass Spectrometers.
Haag AM. Haag AM. Adv Exp Med Biol. 2016;919:157-169. doi: 10.1007/978-3-319-41448-5_7. Adv Exp Med Biol. 2016. PMID: 27975216 Review.
However, it is the mass analyzer that is responsible for determing the mass-to-charge ratio (m/z) of the ions (Jennings KR, Dolnikowski GG, Method Enzymol 193:37-61, 1990). ...This becomes important in the field of molecular biology, where biomolecules may be of low molecu …
However, it is the mass analyzer that is responsible for determing the mass-to-charge ratio (m/z) of the ions (Jennings KR, Dolnikows …
Erratum for the Research Article: "The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation" by D. P. Kodack, V. Askoxylakis, G. B. Ferraro, Q. Sheng, M. Badeaux, S. Goel, X. Qi, R. Shankaraiah, Z. A. Cao, R. R. Ramjiawan, D. Bezwada, B. Patel, Y. Song, C. Costa, K. Naxerova, C. S. F. Wong, J. Kloepper, R. Das, A. Tam, J. Tanboon, D. G. Duda, C. R. Miller, M. B. Siegel, C. K. Anders, M. Sanders, M. V. Estrada, R. Schlegel, C. L. Arteaga, E. Brachtel, A. Huang, D. Fukumura, J. A. Engelman, R. K. Jain.
[No authors listed] [No authors listed] Sci Transl Med. 2019 Jan 30;11(477):eaaw6935. doi: 10.1126/scitranslmed.aaw6935. Sci Transl Med. 2019. PMID: 30700575 No abstract available.
Correction for the Research Article: "The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice" by P. Zheng, B. Zeng, M. Liu, J. Chen, J. Pan, Y. Han, Y. Liu, K. Cheng, C. Zhou, H. Wang, X. Zhou, S. Gui, S. W. Perry, M. Wong, J. Licinio, H. Wei, and P. Xie.
[No authors listed] [No authors listed] Sci Adv. 2019 Jun 21;5(6):eaay2759. doi: 10.1126/sciadv.aay2759. eCollection 2019 Jun. Sci Adv. 2019. PMID: 31245543 Free PMC article.
International Collaborations Are Essential for Stroke.
Fisher M, Amarenco P, Aronowski J, Furie KL, Hillis AE, Lo EH, Schabitz WR, Wong KSL. Fisher M, et al. Stroke. 2019 Nov;50(11):2993-2994. doi: 10.1161/STROKEAHA.119.027674. Epub 2019 Oct 15. Stroke. 2019. PMID: 31610762 Free article. No abstract available.
Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer.
Qu X, Zhang Y, Sang X, Ren D, Zhao H, Wong STC. Qu X, et al. Cancers (Basel). 2022 Jun 29;14(13):3195. doi: 10.3390/cancers14133195. Cancers (Basel). 2022. PMID: 35804965 Free PMC article. Review.
Methyladenosine modifications are the most abundant RNA modifications, including N6-methyladenosine (m(6)A), N1-methyladenosine (m(1)A), and 2'-O-methyladenosine (m(6)A(m)). ...Meanwhile, m(6)A, m(1)A, and m(6)A(m) modificat …
Methyladenosine modifications are the most abundant RNA modifications, including N6-methyladenosine (m(6)A), N1-methyladenosine (m …
5,622 results